The United States Patent and Trademark Office has granted Peplin Biotech (ASX: PEP) a patent protecting the broad anti-cancer activity of its angeloyl-substituted ingenanes - a class of molecules which includes its lead molecule PEP005. [ + ]

In an unusual move, Amrad (ASX: AML) CEO Pete Smith has asked for options that are due to be granted him after approval at next month's AGM to be granted at the same exercise price as those granted to other employees of the company. [ + ]

Animal health and stem-cell company Vet Biotechnology has advanced to the starting gate - and is readying to list on the Newcastle Stock Exchange in late October. [ + ]

Having waved goodbye to its first biotech alumnus Living Cell Technologies (ASX:LCT) earlier this year, the Newcastle Stock Exchange is expecting a number of fresh biotech companies to list on the exchange this year. [ + ]

Rockeby biomed (ASX: RBY) has lodged a 501(k) submission for regulatory approval of its systemic candidiasis diagnostic SysCan3 with the United States Food and Drug Administration. [ + ]

Analysts say that the IPO market for biotech companies in Australia is healthy right now, and they don't foresee any problems in the near future. [ + ]

Bionomics (ASX: BNO) has set up a US subsidiary to hold intellectual property coming out of its US collaborations. [ + ]

Biosignal (ASX:BOS) and the Institute for Eye Research Ltd (IER) have reported interim results from recent in vitro trials of contact lenses with permanently attached furanones. [ + ]

Alchemia (ASX: ACL) will commence the preclinical studies necessary to take its lead anti-cancer compound into human clinical trials after positive results from studies in an animal model of lung cancer. [ + ]

The share price of Genetic Technologies (ASX: GTG) has risen over 50 per cent since the judge in GTG's lawsuit against Applera ruled largely in the company's favour during the Markman hearing last Thursday. [ + ]

Researchers from Monash University's Department of Epidemiology and Preventive Medicine are claiming to have revolutionised knee scans with the development of technology that harnesses the power of magnetic resonance imaging (MRI).

Significant abnormalities observed in cloned mice help reinforce the need to continue to avoid the reproductive cloning of humans, claims Dr Takumi Takeuchi, from Cornell University.

Ongoing research into how the mammalian genome works could lead to major advances in livestock production, according to CSIRO Livestock Industries' researcher, Dr Brian Dalrymple.

Monash researcher Dr Jamie Rossjohn has received a Prime Minister's award for his contribution to science.

Biotech consultant Dr Lyndal Thorburn has been named the 2004 Telstra Business Woman of the Year for the ACT. [ + ]